Department of Orthopedics, Jinan University, Guangzhou, Guangdong Province, China.
Department of Orthopedics, the Second Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, China.
Histol Histopathol. 2021 Jul;36(7):785-794. doi: 10.14670/HH-18-341. Epub 2021 Apr 20.
β-Ecdysone has been reported to perform a protective effect to prevent interleukin 1β (IL-1β)-induced apoptosis and inflammatory response in chondrocytes. In our study, the chondroprotective effects of β-Ecdysone were explored in a mouse model of collagenase-induced osteoarthritis (OA).
Injection of collagenase in the left knee was implemented to establish a mouse model of OA. The histomorphological analysis was detected using safranine O staining. Serum pro-inflammatory cytokines were measured by ELISA assays. Protein expression in the femur and chondrocytes was analyzed using western blot. Chondrocyte apoptosis was evaluated by terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) staining.
Treatment of OA mice with β-Ecdysone supplementation significantly inhibited the production of pro-inflammatory cytokines. Histologic examination exhibited that the degradation of proteoglycans and the loss of trabecular bone were observed in collagenase-injected mice. However, OA-like changes were attenuated by β-Ecdysone administration in collagenase-injected mice. Both in vivo and in vitro models, nuclear forkhead box O1 (FOXO1) protein expression was significantly reduced in the femur of collagenase-treated mice and IL-1β-stimulated chondrocytes. However, β-Ecdysone treatment was able to rescue FOXO1 protein expression in the nucleus to inhibit the transcription and translation of a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4 (ADAMTS-4) and ADAMTS-5.
The findings suggested that β-Ecdysone functioned as a FOXO1 activator to protect collagenase-induced cartilage damage. FOXO1 might be a potential molecular target of β-Ecdysone for the effective prevention and treatment of OA.
已有研究报道,蜕皮甾酮可通过抑制白介素 1β(IL-1β)诱导的软骨细胞凋亡和炎症反应发挥保护作用。本研究旨在探讨蜕皮甾酮对胶原酶诱导的骨关节炎(OA)小鼠模型的软骨保护作用。
通过向左侧膝关节注射胶原酶建立 OA 小鼠模型。采用番红 O 染色法进行组织形态学分析。通过 ELISA 检测试剂盒检测血清促炎细胞因子。采用 Western blot 分析股骨和软骨细胞中的蛋白表达。采用末端脱氧核苷酸转移酶介导的缺口末端标记(TUNEL)染色法评估软骨细胞凋亡。
OA 小鼠补充蜕皮甾酮治疗可显著抑制促炎细胞因子的产生。组织学检查显示,胶原酶注射小鼠的软骨蛋白聚糖降解和小梁骨丢失。然而,OA 样改变在胶原酶注射小鼠中被蜕皮甾酮治疗所减弱。体内和体外模型均显示,胶原酶处理的小鼠股骨和 IL-1β 刺激的软骨细胞中核叉头框 O1(FOXO1)蛋白表达显著降低。然而,蜕皮甾酮治疗能够挽救 FOXO1 蛋白在核中的表达,抑制解整合素样金属蛋白酶与富含亮氨酸重复序列 5(ADAMTS-5)和 ADAMTS-4 的转录和翻译。
这些发现表明,蜕皮甾酮作为 FOXO1 激活剂发挥作用,可保护胶原酶诱导的软骨损伤。FOXO1 可能是蜕皮甾酮有效预防和治疗 OA 的潜在分子靶点。